Literature DB >> 3639953

Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis.

M H Stoler, T A Eskin, S Benn, R C Angerer, L M Angerer.   

Abstract

Patients with the acquired immunodeficiency syndrome (AIDS) are subject to a spectrum of central nervous system (CNS) disorders. Recent evidence implicates the human T-cell lymphotropic virus type III (HTLV-III) in the pathogenesis of some of these illnesses, although, the cells infected by the virus have yet to be identified. Using in situ hybridization, we examined brain tissue from two patients with AIDS encephalopathy for the presence of HTLV-III RNA. In both cases, viral RNA was detected and concentrated in, though not limited to, the white matter. The CNS cells most frequently infected included macrophages, pleomorphic microglia, and multinucleated giant cells. Less frequently, cells morphologically consistent with astrocytes, oligodendroglia, and rarely neurons were also infected. The findings strengthen the association of HTLV-III with the pathogenesis of AIDS encephalopathy. In situ hybridization can be applied to routinely prepared biopsy tissue in the diagnosis of HTLV-III infection of the CNS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3639953

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  77 in total

1.  The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.

Authors:  E C Darcissac; M J Truong; J Dewulf; Y Mouton; A Capron; G M Bahr
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration.

Authors:  K Kure; K M Weidenheim; W D Lyman; D W Dickson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients.

Authors:  I M Balluz; M A Farrell; E Kay; M J Staunton; J N Keating; O Sheils; S L Cosby; M J Mabruk; B J Sheahan; G J Atkins
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

Review 4.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

5.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Authors:  L M Dallasta; L A Pisarov; J E Esplen; J V Werley; A V Moses; J A Nelson; C L Achim
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

6.  Human immunodeficiency virus type 1 infection of neural xenografts.

Authors:  T A Cvetkovich; E Lazar; B M Blumberg; Y Saito; T A Eskin; R Reichman; D A Baram; C del Cerro; H E Gendelman; M del Cerro
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Sequences from myeloblastosis-associated virus MAV-2(O) and UR2AV involved in the formation of plaques and the induction of osteopetrosis, anemia, and ataxia.

Authors:  R E Aurigemma; J L Torgersen; R E Smith
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.